Flavonoids activate wild-type p53

Oncogene

Volumn 13, Issue 8, 1996, Pages 1605-1614

  Plaumann, Bettina ^a   Pritsche, Michael ^b   Rimpler, Horst ^a   Brandner, Gerhard ^a   Hess, Ralf D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Apoptosis; Cell cycle; DNA damage; Flavonoids; G2M; p53

Indexed keywords

APIGENIN; DNA BINDING PROTEIN; FLAVONOID; LUTEOLIN; PROTEIN P53; QUERCETIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; KINETICS; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN INDUCTION;

ANIMALS; APOPTOSIS; CELL LINE; FLAVONOIDS; G2 PHASE; MICE; MICE, INBRED C3H; MITOSIS; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0029912852     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Agarwal ML, Agarwal A, Taylor WT and Stark GR. (1995). Proc. Natl. Acad. Sci. USA, 92, 8493 - 8497.
2. Ahmad MS, Fazal F, Rahman A, Hadi SM and Parish JH. (1992). Carcinogenesis, 13, 605 - 608.
3. Ahmed MS, Ainley K, Parish JH and Hadi SM. (1994). Carcinogenesis, 15, 1627 - 1630.
4. Aloni-Grinstein R, Schwartz D and Rotter V. (1995). EMBO J., 14, 1392 - 1401.
5. Askew DS, Ashmun RA, Simmons BC and Cleveland JL. (1991). Oncogene, 6, 1915 - 1922.
6. Austin C, Patel S, Ono K, Nakane H and Fisher LM. (1992). Biochem. J., 282, 883 - 889.
7. Babich H and Borenfreund E. (1987). Toxic, in vitro, 1, 3 - 9.
8. Barak Y, Juven T, Haffner R and Oren M. (1993). EMBO J., 12, 461 - 468.
9. Borenfreund E, Babich H, Martin-Alguacil N. (1988). Toxic. in vitro, 2, 1 - 6.
10. Canada AT, Gianella E, Nyguen TD and Mason RP. (1990). Free Radic. Biol. Med., 9, 441 - 449.
11. Caria H, Chaveca T, Laires A and Rueff J. (1995). Mutat. Res.: Genetic Toxicology, 343, 85 - 94.
12. Chen RR. (1977). Exp. Cell. Res., 104, 255 - 262.
13. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature, 362, 849 - 852.
14. Enoch T and Norbury C. (1995). Trends Biochem. Sci., 20, 426 - 430.
15. Fiala ES, Reddy BS and Weisberger JH. (1985). Annu. Rev. Nutr., 5, 295 - 321.
16. Fritsche M, Haessler C and Brandner G. (1993). Oncogene, 8, 307 - 318.
17. Gannon JV, Greaves R, Iggo R and Lane D. (1990). EMBO J., 9, 1591 - 1602.
18. Gorczyca W, Gong J, Ardelt B, Traganos F and Darzynkiewicz D. (1993). Cancer Res., 53, 3186 - 3192.
19. Graham FL and van der Ebb AJ. (1973). Virology, 52, 456 - 467.
20. Green H and Meuth M. (1974). Cell, 3, 127 - 133.
21. Guillof C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B and Liebermann DA. (1995). Oncogene, 10, 2263 - 2270.
22. Gurney JV, Harrison RO and Fenno J. (1980). J. Virol., 34, 752 - 763.
23. Halazonetis TD, Davis LJ and Kandill AN. (1993). EMBO J., 12, 1021 - 1028.
24. Henderson D and Hurley LH. (1995). Nature Medicine, 1, 525 - 527.
25. Hotz MA, Gong J, Traganos F and Darzynkiewicz Z. (1994). Cytometry, 15, 237 - 244.
26. Juven T, Barak Y, Zauberman A, George DL and Oren M. (1993). Oncogene, 8, 4311 - 4316.
27. Kantengwa S and Polla BS. (1991). Biochem. Biophys. Res. Commun., 180, 308 - 314.
28. Kinoshita T, Sankawa U, Takuma T, Asahi K and Takahashi N. (1985). Chem. Pharm. Bull., 33, 4109-4112.
29. Kühnau J. (1976). World. Rev. Nutr. Diet., 24, 117 - 191.
30. Lane DP. (1992). Nature, 358, 15 - 16.
31. Laughton MJ, Halliwell B, Evans PJ and Hoult JR. (1989). Biochem. Pharmacol., 38, 2859 - 2865.
32. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993a). Cell, 74, 957 - 967.
33. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993b). Nature, 362, 847 - 849.
34. Manach C, Morand C, Texier O, Favier M-L, Agullo C, Demigne C, Regerat F and Remesy C. (1995). J. Nutr., 125, 1911 - 1922.
35. Markaverich BM, Roberts RR, Finney RW and Clark JH. (1983). J. Biol. Chem., 258, 11663 - 11671.
36. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H and Aoike A. (1993). Cancer Res., 53, 1328 - 1331.
37. McGregor JT. (1986). In: Knudsen I (ed.) Genetic Toxicology of the Diet, Alan R, Riss, New York pp. 33 - 34.
38. Müller R, Mumberg D and Lucibello FC. (1993). Biochem. Biophys. Acta, 1155, 151 - 179.
39. Ochiai M, Nagao M, Wakabayashi K and Sugimura T. (1984). Mutat. Res., 129, 19 - 24.
40. Pennie WD and Campo MS. (1992). Virology, 190, 861 - 865.
41. Rahman A, Shahabuddin, Hadi SM, Parish JH and Ainley K. (1989). Carcinogenesis, 10, 1833 - 1839.
42. Renzing J and Lane DP. (1995). Oncogene, 10, 1865 - 1868.
43. Sahu SC and Gray GC. (1994). Cancer Lett., 85, 159 - 164.
44. Sato F, Matsukawa Y, Mazsumoto K, Nishino H and Sakai T. (1994). Biochem. Biophys. Res. Commun., 204, 578 - 584.
45. Selvakumaran M, Lin Hk, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B and Liebermann D. (1994). Oncogene, 9, 1791 - 1798.
46. Shimoi K, Masuda S, Furugori M, Esaki S and Kinac N. (1994). Carcinogenesis, 15, 2669 - 2672.
47. Siegel J, Fritsche M, Mai S, Brandner G and Hess RD. (1995). Oncogene, 11, 1363 - 1370.
48. Steward N, Hicks GG, Paraskevas F and Mowat M. (1995). Oncogene, 10, 109 - 115.
49. Thompson RS, Jacques D, Haslam E and Tanner RJN. (1972). J. Chem. Soc. Perkin Trans., 1, 1387.
50. Torel J, Cillard J and Cillard P. (1994). Phytochemistry, 26, 2489 - 2491.
51. Wang Y and Prives C. (1995). Nature, 376, 89 - 91.
52. Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K and Uchida A. (1994). Cancer Res., 54, 4952 - 4957.
53. Yonish-Rouach E, Grunwald D. Wilder S, Kimchi A, May E, Lawrence Jj, May P and Oren M. (1993). Mol. Cell. Biol., 13, 1415 - 1423.
54. Zhang W, Funk WD, Wright WE, Shay JW and Deisseroth A. (1993). Oncogene, 8, 2555 - 2559.